Sc. Yoon et al., CLINICAL-RESULTS OF 24 PITUITARY MACROADENOMAS WITH LINAC-BASED STEREOTACTIC RADIOSURGERY, International journal of radiation oncology, biology, physics, 41(4), 1998, pp. 849-853
Citations number
21
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: To determine the impact of stereotactic radiosurgery (SRS) on
the clinical course, hormonal status, and follow-up CT/MRI scan of pi
tuitary macroadenomas. Methods and Materials: From July 1988 to March
1996, W pituitary macroadenomas had been treated using 6 MV linear acc
elerator based SRS. They consisted of II (45.8%) prolactinomas, 2 (8.3
%) growth hormone (GH)-secreting tumors, 1 (4.2%) Gushing's disease, 8
(33.3%) nonsecreting (nonfunctioning: NF) tumors, and 2 (8.3%) mixed
prolactin-growth hormone (PRL-GH)-secreting tumors (M:F = 12:12; aged
21-61 years). Postoperative irradiation was performed in all cases exc
ept for the instance of Gushing's disease. The prescribed dose to tumo
r center varied from 10 to 27 Gy (mean 21.1 Gy) using a collimator siz
e of 0.5 to 2.5 cm. The follow-up duration ranged from 13 to 89 months
(mean 49.2 months). Results from these patients mere compared to our
results using conventional radiation. Results: Visual acuity and field
defect were improved or became normal in 19 (79.2%) cases. Four (16.7
%) remained unchanged after the treatment. One (4.1%) progressed 6 yea
rs after SRS and subsequently had repeat surgery with conventional boo
st irradiation. Of the 13 (46.4%) prolactinomas, including two mixed P
RL-GH secreting tumors, 11 (84.1%) revealed normal hormonal levels wit
hin 1 year after SRS. In contrast, it took 2 years to become normal af
ter conventional radiation therapy. In four GH-secreting tumors includ
ing two mixed PRL-GH secreting tumors, SRS and conventional methods sh
owed similar responses. On follow-up imagings of the 21 patients, the
mass was completely resolved in 4 (16.7%), including 3 PRLs and one NF
, decreased in 11 (45.8%), and unchanged in 5 (16.7%) with central nec
rosis or cysts. One (4.2%) progressed and was reoperated 6 years after
treatment. The complications related to SRS were comparable to those
from conventional method. Conclusion: Radiosurgery can be used effecti
vely in patients with pituitary adenoma. In this study, a more rapid h
ormonal and clinical response was achieved with radiosurgery than with
conventional pituitary irradiation treatment. (C) 1998 Elsevier Scien
ce Inc.